Julie An Marie Talano, MD

CHILDREN'S HOSPITAL OF WISCONSIN SINCE 1999
Associate professor, the Medical College of Wisconsin

Office Locations

8915 W. Connell Ave
Milwaukee, WI 53226
(414)266-4850 (appointment)
414-955-4170 (office)
(414)266-2681 (Bone marrow transplant referrals and second opinions)
(414) 266-4850 (clinic)

Overview

Best Doctors 2013Children deserve the best and the most advanced medical care.  When a child is diagnosed with cancer or a disorder which requires a bone marrow transplant, our desire is to offer them the most cutting edge care with novel research initiatives. The ultimate goal is to help improve survival and lessen the side effects of transplantation.  By leading the bone marrow transplant clinical research team, Dr. Talano’s strive to bring from the bench to the bedside opportunities to each patient to help improve upon our prior results. We treat every child as if they are our own- and strive every day to make a difference.

Certifications
Pediatric Hematology-Oncology, Pediatrics
Areas of Interest
  • BMT for leukemia
  • BMT for sickle cell disease
  • Alternative donors for bone marrow transplant
  • Hemophagocytic lymphohistiocytosis
  • Cancer

Education & Awards

Education
  • 1995, Northwestern University (Evanston, IL), MD
Residency
  • 1998, Children's Memorial Hospital (Chicago, IL)
Fellowship
  • 2003, Medical College of Wisconsin
Awards
  • 11/2006 Best Abstract, National Marrow Donor Program Council Meeting
  • 2009 - 2013 Included in Best Doctors in America
  • 2011 Included in Super Doctors

Research & Publications

Research

Alternative donor blood and marrow transplantation, hemophagocytic lymphohistiocytosis, blood and marrow transplantation for leukemias, and cellular therapy.

Grants

Title: Phase 1 Multi-viral CTLs for Recipients of Grafts Rigorously Depleted of T Cells
Source: Clinical & Translational Science Institute
Role: Co-Principal Investigator
PI: Taylor, Carolyn PhD & Talano, Julie MD
Dates: 6/1/2011 - 5/31/2013
Direct Funds: $50,000

Title: Haploidentical Transplantation for patients with severe Sickle Cell Disease
Source: Busulfex
Role: Co-Principal Investigator
Dates: 1/1/2012 - 12/31/2013
Direct Funds: $25,000 (1 year)

Title: Hyundai Hope on Wheels for Pediatric Cancer Award
Source: Hyundai/Children's Hospital of Wisconsin
Role: Principal Investigator
Dates: 9/1/2012 - 8/31/2015
Direct Funds: $250,000

Title: Haploidentical Transplantation for patients with severe Sickle Cell Disease
Source: FDA RO1
Role: Co-PI
Dates: 1/1/2013-12/31/2015
Direct Funds: $50,000 (3 year)

 

  • Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients.
  • The use of novel Therakos™ Cellex® for extracorporeal photopheresis in treatment of graft-versus-host disease in paediatric patients.
  • Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.
  • Clinical outcomes of children receiving intensive cardiopulmonary support during hematopoietic stem cell transplant.
  • Monitoring and prevention of relapse after allogeneic hematopoietic cell transplantation for myeloid malignancies.

 View all publications from Julie An Talano, MD.